Jeff Ho

Jeff Ho has a diverse work experience spanning over several companies in the biopharmaceutical industry. Jeff is currently employed at Surrozen as the VP of Corporate Development and Strategy, a position they have held since June 2022. Prior to this, from December 2017 to June 2022, Jeff worked at InCarda Therapeutics as the Vice President of Commercial Strategy.

Before joining InCarda Therapeutics, Jeff held various roles at Jazz Pharmaceuticals, including Global Molecule Lead for the Asparaginase Franchise from January 2016 to November 2017. Jeff also served as the Director of New Product Planning from July 2013 to December 2015 and as the Director of Market Intelligence from September 2010 to June 2013.

Jeff's earlier experiences include working as an Associate Director of Commercial Strategy at Gilead Sciences from October 2005 to September 2010 and as a Manager of Market Research and Analytics at Schering Plough Pharmaceuticals from October 2001 to October 2005. Jeff began their career as a Consultant at Front Line Strategic Consulting (now Navigant) from August 1999 to October 2001.

Jeff Ho obtained their Bachelor of Arts (B.A.) degree in Economics from Stanford University from 1995 to 1999. After that, they pursued further education at the University of California, Berkeley, Haas School of Business, where they obtained their MBA in Business Administration from 2007 to 2010.